The safety of novel drugs used to treat irritable bowel syndrome

Author： Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.5, 2014-05, pp. : 625-638

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

By Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 403-421

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for irritable bowel syndrome

By Shekhar Chander   Whorwell Peter J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 4, 2009-12 ,pp. : 673-685

Informa Healthcare

Access to resources Recommend Favorite

The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel Syndrome

By Meyers NL   Hickling RI  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 848-866

Field House Publishing

Access to resources Recommend Favorite

New Drugs in the Management of the Irritable Bowel Syndrome

By Farthing M.J.G.  

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 11-21

Adis International

Access to resources Recommend Favorite

The use of psychotropic drugs in irritable bowel syndrome

By Dekel Roy   Drossman Douglas A   Sperber Ami D  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 329-339

Informa Healthcare

Access to resources Recommend Favorite